# Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)

> **NCT00153530** · PHASE4 · COMPLETED · sponsor: **Charite University, Berlin, Germany** · enrollment: 604 (estimated)

## Conditions studied

- Central Nervous System Lymphoma

## Interventions

- **DRUG:** methotrexate
- **RADIATION:** radiotherapy

## Key facts

- **NCT ID:** NCT00153530
- **Lead sponsor:** Charite University, Berlin, Germany
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2000-05
- **Primary completion:** —
- **Final completion:** 2009-05
- **Target enrollment:** 604 (ESTIMATED)
- **Last updated:** 2009-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00153530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00153530, "Whole Brain Irradiation in Primary Central Nervous System (CNS) Lymphoma (PCNSL)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00153530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*